Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 7, 2009; 15(25): 3153-3160
Published online Jul 7, 2009. doi: 10.3748/wjg.15.3153
Published online Jul 7, 2009. doi: 10.3748/wjg.15.3153
Male general population | Male cancer survivors | ||||||
Strategy (abreviation) | Lifetime cost per person (dollar)1 | Life expectancy (yr) | Incremental C/E2, dollar1 per life-year gained | Strategy (abreviation) | Lifetime cost per person (dollar)1 | Life expectancy (yr) | Incremental C/E2, dollar1 per life-year gained |
COL every 10 yr | 437.3 | 17.260 | … | COL every 5 yr | 463.5 | 7.572 | |
No screening | 448.0 | 17.243 | … | COL every 10 yr | 480.1 | 7.568 | … |
COL every 5 yr | 478.3 | 17.263 | 14 456.8 | COL every 3 yr | 480.2 | 7.575 | 5592.9 |
DCBE every 5 yr | 542.3 | 17.256 | … | DCBE every 5 yr | 563.4 | 7.562 | … |
SIG every 5 yr | 542.4 | 17.255 | … | SIG every 5 yr | 571.8 | 7.560 | … |
COL every 3 yr | 554.4 | 17.265 | 38 876.8 | No screening | 632.2 | 7.544 | … |
FOBT every 2 yr | 810.0 | 17.252 | … | FOBT every 2 yr | 735.2 | 7.557 | … |
FOBT every 1 yr | 1130.9 | 17.257 | … | FOBT every 1 yr | 842.3 | 7.564 | … |
- Citation: Park SM, Kim SY, Earle CC, Jeong SY, Yun YH. What is the most cost-effective strategy to screen for second primary colorectal cancers in male cancer survivors in Korea? World J Gastroenterol 2009; 15(25): 3153-3160
- URL: https://www.wjgnet.com/1007-9327/full/v15/i25/3153.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3153